2
Portfolio companies merged
A Private Equity fund partnered with EFESO to accelerate and secure the Post-Merger Integration of two pharmaceutical portfolio companies. The objective was clear: ensure a seamless merger, fully capture expected synergies within six months, and establish a scalable operating model for growth. EFESO orchestrated the integration across five countries, ultimately outperforming the original financial ambition.
Industry: Life Sciences
Industry: Private Equity
Service: Carve-out & Merger Integration
Service: Operations Due Diligence
Service: Transactions and Turnaround
A Private Equity fund managing multiple healthcare and pharmaceutical assets with a strategic focus on operational excellence and accelerated value creation. The merged portfolio companies operate across five countries, manufacturing and distributing pharmaceutical products and leveraging complementary capabilities to expand global market reach.
2
Portfolio companies merged
5
Countries involved in the integration
The Private Equity fund required a fast and robust integration to secure the value thesis behind the acquisition. Expectations were ambitious and time-bound:
The merger delivered results beyond the original financial objectives, demonstrating the impact of a structured and capability-driven Post-Merger Integration.
+15%
Additional synergies on operational costs
+13%
CAGR on revenue (organic growth) for the three-year plan
EFESO executed an integration roadmap that balanced strategic ambition with operational pragmatism:
This methodology ensured synergy realization while enabling the merged company to operate as one cohesive, future-ready organization.